302 related articles for article (PubMed ID: 19514086)
1. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected].
Nakamura T; Matsumine A; Yamakado K; Matsubara T; Takaki H; Nakatsuka A; Takeda K; Abo D; Shimizu T; Uchida A
Cancer; 2009 Aug; 115(16):3774-81. PubMed ID: 19514086
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.
Yamakado K; Hase S; Matsuoka T; Tanigawa N; Nakatsuka A; Takaki H; Takao M; Inoue Y; Kanazawa S; Inoue Y; Sawada S; Kusunoki M; Takeda K
J Vasc Interv Radiol; 2007 Mar; 18(3):393-8. PubMed ID: 17377185
[TBL] [Abstract][Full Text] [Related]
3. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
[TBL] [Abstract][Full Text] [Related]
4. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of radiofrequency ablation and metastasectomy in elderly patients with lung metastases from musculoskeletal sarcomas.
Nakamura T; Matsumine A; Yamakado K; Takao M; Uchida A; Sudo A
J Cancer Res Ther; 2013; 9(2):219-23. PubMed ID: 23771362
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
[TBL] [Abstract][Full Text] [Related]
7. Sarcoma lung metastases treated with percutaneous radiofrequency ablation: results from 29 patients.
Palussière J; Italiano A; Descat E; Ferron S; Cornélis F; Avril A; Brouste V; Bui BN
Ann Surg Oncol; 2011 Dec; 18(13):3771-7. PubMed ID: 21638099
[TBL] [Abstract][Full Text] [Related]
8. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention.
Kodama H; Yamakado K; Takaki H; Kashima M; Uraki J; Nakatsuka A; Takao M; Taguchi O; Yamada T; Takeda K
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):563-9. PubMed ID: 21748451
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496
[TBL] [Abstract][Full Text] [Related]
10. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors influencing the development of an iatrogenic pneumothorax for computed tomography-guided radiofrequency ablation of upper renal tumor.
Park BK; Kim CK
Acta Radiol; 2008 Dec; 49(10):1200-6. PubMed ID: 19031183
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD
J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors.
Hiraki T; Sakurai J; Tsuda T; Gobara H; Sano Y; Mukai T; Hase S; Iguchi T; Fujiwara H; Date H; Kanazawa S
Cancer; 2006 Dec; 107(12):2873-80. PubMed ID: 17096433
[TBL] [Abstract][Full Text] [Related]
14. Image-guided radiofrequency ablation for adrenocortical adenoma with Cushing syndrome: outcomes after mean follow-up of 33 months.
Arima K; Yamakado K; Suzuki R; Matsuura H; Nakatsuka A; Takeda K; Sugimura Y
Urology; 2007 Sep; 70(3):407-11. PubMed ID: 17905083
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1306-12. PubMed ID: 17976467
[TBL] [Abstract][Full Text] [Related]
17. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
[TBL] [Abstract][Full Text] [Related]
18. Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma.
Yan TD; King J; Sjarif A; Glenn D; Steinke K; Al-Kindy A; Morris DL
Ann Surg Oncol; 2007 May; 14(5):1718-26. PubMed ID: 17285398
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer.
Lanuti M; Sharma A; Digumarthy SR; Wright CD; Donahue DM; Wain JC; Mathisen DJ; Shepard JA
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):160-6. PubMed ID: 19154919
[TBL] [Abstract][Full Text] [Related]
20. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
